CAN
IMGN

Cetera Advisor Networks’s Immunogen Inc IMGN Stock Holding History

Cetera Advisor Networks’s Portfolio IMGN Stock Details IMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-131
Closed -$1K – 3172
2020
Q2 		$1K Buy
+131
New +$557 ﹤0.01% 3404

Other funds holding IMGN

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Cetera Advisor Networks's IMGN Position: Q3 2020 in Review

Cetera Advisor Networks sold out of Immunogen Inc (IMGN) in Q3 2020, closing a stake of 131 shares — an estimated $1K sold.

Cetera Advisor Networks first reported a position in IMGN in Q2 2020 and held it in 1 quarter. The position peaked at $1K in Q2 2020. 185 funds tracked by Wall St. Rank hold IMGN as of Q3 2020.

  • Cetera Advisor Networks reported no remaining Immunogen Inc position as of Q3 2020 after selling out during the quarter.
  • Cetera Advisor Networks sold 131 Immunogen Inc shares in Q3 2020, an estimated $1K.
  • Cetera Advisor Networks first reported a position in Immunogen Inc in Q2 2020 and held it in 1 quarter.
  • Cetera Advisor Networks's Immunogen Inc position peaked at $1K in Q2 2020.
  • 185 funds tracked by Wall St. Rank held Immunogen Inc as of Q3 2020.

Based on Cetera Advisor Networks's 13F filing for Q3 2020, filed 13 Nov 2020.